Related Experiment Video

Updated: Jun 24, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K

TNIK in disease: from molecular insights to therapeutic prospects

Xue Wu1, Zhe Zhang1,2, Zhenye Qiu1,2

  • 1Xi'an Key Laboratory of Innovative Drug Research for Heart Failure, Faculty of Life Sciences and Medicine, Northwest University, 229 Taibai North Road, Xi'an, 710069, China.

Apoptosis : an International Journal on Programmed Cell Death
|June 9, 2024
PubMed

Insights

TRAF2 and NCK interacting kinase (TNIK) is crucial in cell functions and diseases. Targeting TNIK offers new therapeutic strategies for cancer and neurological disorders.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology
  • Neuroscience

Background:

  • TRAF2 and NCK interacting kinase (TNIK) is a key protein kinase involved in cell motility, proliferation, and differentiation.
  • Aberrant TNIK expression is linked to various cancers and plays a role in neuronal development and synaptic formation.

Purpose of the Study:

  • To summarize biological information on TNIK.
  • To review TNIK's role and regulatory mechanisms in cancer and neuropsychiatric diseases.
  • To introduce research progress on TNIK-targeting inhibitors.

Main Methods:

  • Literature review of TNIK's biological functions.
  • Analysis of TNIK's involvement in disease pathogenesis.
  • Compilation of current research on TNIK inhibitors.

Main Results:

  • TNIK is implicated in both cancer progression and neurological functions.
  • Dysregulation of TNIK contributes to disease development.
  • Inhibitors targeting TNIK show therapeutic potential.

Conclusions:

  • Understanding TNIK's function and regulation is vital for disease treatment.
  • Targeting TNIK presents a promising therapeutic avenue for cancer and neuropsychiatric disorders.
Keywords:
CancersNeurological disordersPsychotic disordersTNIKTNIK inhibitors

More Related Videos

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.6K
Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.6K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K